-
A MULTIDIMENSIONAL FRAMEWORK TO MANAGE REGIONAL STRATEGIC PLANNING FOR ADVANCED THERAPY MEDICINAL PRODUCTS
Aug 11, 2026, 17:15 PM -
EVALUATING COMPLETE RESPONSE (CR) AND PROGRESSION-FREE SURVIVAL (PFS) AS SURROGATE ENDPOINTS FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Aug 11, 2026, 17:15 PM -
EVERY RECORD OR RANK AND STOP? RECALL SAFETY OF AN LLM THAT DECIDES ON ALL RECORDS VERSUS ACTIVE-LEARNING TRIAGE IN SYSTEMATIC REVIEW SCREENING
Aug 11, 2026, 17:15 PM -
USING ABSTRACT-LEVEL EVIDENCE MAPPING TO PRIORITIZE HEALTH ECONOMIC MODELING: APPLICATION TO TAI CHI SYSTEMATIC REVIEWS AND META-ANALYSES
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT AND CARBON CONSEQUENCES OF WEARABLE CARDIOVERTER-DEFIBRILLATOR USE IN FRANCE: A THREE-COHORT ANALYSIS OF NON-ISCHEMIC HEART FAILURE, HEART TRANSPLANT, AND MYOCARDITIS/PPCM
Aug 11, 2026, 17:15 PM -
MEDICATION ADHERENCE, DEPRESSIVE SYMPTOMS AND THEIR CLINICAL PREDICTORS IN CHRONIC KIDNEY DISEASE: FINDINGS FROM A TERTIARY CARE HOSPITAL IN PAKISTAN
Aug 11, 2026, 17:15 PM -
A GLOBAL AI-DRIVEN CODE LIST GENERATION TOOL WITH INTEGRATED JAPANESE MEDICAL DICTIONARY FOR SCALABLE CROSS-COUNTRY REAL-WORLD EVIDENCE
Aug 11, 2026, 17:15 PM -
CONSIDERATION OF HEALTH EQUITY IN HEALTH TECHNOLOGY ASSESSMENTS
Aug 11, 2026, 17:15 PM -
REAL-WORLD EQ-5D-5L UTILITY VALUES IN ADULTS WITH TRANSFUSION-DEPENDENT ß-THALASSEMIA USING UK AND FRENCH VALUE SETS
Aug 11, 2026, 17:15 PM -
SPATIAL AND ECONOMIC MODELING FOR MOBILE STROKE UNIT DEPLOYMENT: A TARGETED REVIEW OF GEOSPATIAL COST-EFFECTIVENESS TO INFORM MODELING STRATEGY
Aug 11, 2026, 17:15 PM -
ASSESSING THE ALIGNMENT BETWEEN ADDED THERAPEUTIC VALUE AND COST-EFFECTIVENESS: AN ANALYSIS OF PORTUGUESE REIMBURSEMENT DECISIONS
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF THE CONNECTED ICU: MOVING FROM REACTIVE TO PROACTIVE HEALTHCARE IN PRIVATE HOSPITALS
Aug 11, 2026, 17:15 PM -
REAL-TIME CLINICAL TRIAL LANDSCAPE INTELLIGENCE: DEVELOPMENT AND VALIDATION OF AN AUTOMATED SURVEILLANCE PLATFORM
Aug 11, 2026, 17:15 PM -
PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) PATIENTS IN THE NETHERLANDS
Aug 11, 2026, 17:15 PM -
A SYSTEMATIC LITERATURE REVIEW (SLR) AND INDIRECT TREATMENT COMPARISON (ITC) FEASIBILITY ASSESSMENT IN HOMOLOGOUS RECOMBINATION REPAIR (HRR)-DEFICIENT METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (MCSPC)
Aug 11, 2026, 17:15 PM -
INSIDE CEESP TECHNICAL EXCHANGES: METHODOLOGICAL SIGNALS FROM RECENT FRENCH ECONOMIC ASSESSMENTS
Aug 11, 2026, 17:15 PM -
ECONOMIC VALUE OF TREATING AND REDUCING THE BURDEN OF ATOPIC DERMATITIS AND COMORBID ASTHMA IN PAEDIATRIC PATIENTS USING DUPILUMAB: A DUTCH SOCIETAL COST-CONSEQUENCE ANALYSIS
Aug 11, 2026, 17:15 PM -
CHRONIC KIDNEY DISEASE SCREENING AMONG PATIENTS TREATED FOR TYPE 2 DIABETES AND/OR HYPERTENSION IN GREECE: NATIONWIDE REAL-WORLD EVIDENCE FROM THE ELECTRONIC PRESCRIPTION SYSTEM
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF A RAPID MULTIPLEX PCR TEST FOR SEPSIS AND ANTIMICROBIAL RESISTANCE MANAGEMENT IN ICU PATIENTS
Aug 11, 2026, 17:15 PM -
POPULATION-LEVEL IMPACT OF POLATUZUMAB AND GLOFITAMAB IN ALGERIA: A 15-YEAR PROJECTION
Aug 11, 2026, 17:15 PM
